{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:06:48Z","timestamp":1778663208025,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1124\/jpet.116.234146","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T01:09:30Z","timestamp":1468285770000},"page":"464-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676"],"prefix":"10.1016","volume":"358","author":[{"given":"Katarina","family":"Varn\u00e4s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Jur\u00e9us","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Johnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Ahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4r","family":"Sch\u00f6tt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Schou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Jerning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Malmborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovisa","family":"Afzelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Farde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.234146_bib48","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/sj.npp.1300235","article-title":"Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat","volume":"28","author":"\u00c5hlander-L\u00fcttgen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.234146_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.nucmedbio.2010.08.006","article-title":"Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds","volume":"38","author":"Andersson","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1124\/jpet.116.234146_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/jm00140a002","article-title":"8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist","volume":"24","author":"Arvidsson","year":"1981","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.116.234146_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00228-003-0643-x","article-title":"Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development","volume":"59","author":"Bergstr\u00f6m","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.116.234146_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(93)90956-I","article-title":"Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat","volume":"234","author":"Carli","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.234146_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(92)90533-A","article-title":"8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task","volume":"211","author":"Carli","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.234146_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ilar.38.1.41","article-title":"Special Report: The 1996 Guide for the Care and Use of Laboratory Animals","volume":"38","author":"Clark","year":"1997","journal-title":"ILAR J"},{"key":"10.1124\/jpet.116.234146_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/jpet.112.202895","article-title":"Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography","volume":"346","author":"Comley","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234146_bib8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2967\/jnumed.110.084525","article-title":"SEP-225289 serotonin and dopamine transporter occupancy: a PET study","volume":"52","author":"DeLorenzo","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1124\/jpet.116.234146_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroimage.2013.08.001","article-title":"Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD","volume":"86","author":"Ding","year":"2014","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.116.234146_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2005.01.015","article-title":"Studies of drug binding to plasma proteins using a variant of equilibrium dialysis","volume":"38","author":"Eriksson","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/jpet.116.234146_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0773.1995.tb00165.x","article-title":"Differences in brain 5-HT transporter dissociation rates among animal species","volume":"76","author":"Erreboe","year":"1995","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.116.234146_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s002130050391","article-title":"PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain","volume":"133","author":"Farde","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.234146_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2009.03.002","article-title":"Target site occupancy: emerging generalizations from clinical and preclinical studies","volume":"122","author":"Grimwood","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.116.234146_bib14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/jcbfm.2012.1","article-title":"Combining PET biodistribution and equilibrium dialysis assays to assess the free brain concentration and BBB transport of CNS drugs","volume":"32","author":"Gunn","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.116.234146_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(96)01131-6","article-title":"Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635","volume":"745","author":"Hall","year":"1997","journal-title":"Brain Res"},{"key":"10.1124\/jpet.116.234146_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/jpet.107.133082","article-title":"Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)","volume":"325","author":"Hirst","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234146_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-3565(24)37012-0","article-title":"The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299","volume":"283","author":"Johansson","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234146_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02246046","article-title":"Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man","volume":"119","author":"Karlsson","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.234146_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02245691","article-title":"PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor","volume":"113","author":"Karlsson","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.234146_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.116.234146_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.116.234146_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-011-2456-4","article-title":"The scopolamine model as a pharmacodynamic marker in early drug development","volume":"220","author":"Lenz","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.234146_bib23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/jpet.104.079319","article-title":"Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding","volume":"313","author":"Liu","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234146_bib24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuropharm.2005.01.007","article-title":"Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat","volume":"48","author":"L\u00fcttgen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.116.234146_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.109.150722","article-title":"[N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy","volume":"330","author":"Maier","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234146_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.329.5991.502","article-title":"Is pharma running out of brainy ideas?","volume":"329","author":"Miller","year":"2010","journal-title":"Science"},{"key":"10.1124\/jpet.116.234146_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.bjp.0702098","article-title":"Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat","volume":"125","author":"Misane","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.116.234146_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0893-133X(99)00109-8","article-title":"Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT","volume":"22","author":"Misane","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.234146_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2008.02.023","article-title":"The role of 5-HT(1A) receptors in learning and memory","volume":"195","author":"\u00d6gren","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.116.234146_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/360161a0","article-title":"A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors","volume":"360","author":"Oksenberg","year":"1992","journal-title":"Nature"},{"key":"10.1124\/jpet.116.234146_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2125.2008.03348.x","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects","volume":"67","author":"Patat","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.116.234146_bib31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.neuroimage.2008.02.063","article-title":"[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain","volume":"41","author":"Pierson","year":"2008","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.116.234146_bib32","first-page":"208","article-title":"Preclinical development of a radioligand for studies of central 5-HT1A receptors in vivo - [11C]WAY 100635","volume":"5","author":"Pike","year":"1995","journal-title":"Med Chem Res"},{"key":"10.1124\/jpet.116.234146_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/026988110201600301","article-title":"Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride","volume":"16","author":"Rabiner","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.116.234146_bib34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-014-0217-5","article-title":"Serotonergic therapies for cognitive symptoms in Alzheimer\u2019s disease: rationale and current status","volume":"74","author":"Ramirez","year":"2014","journal-title":"Drugs"},{"key":"10.1124\/jpet.116.234146_bib35","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/cbdv.200900103","article-title":"Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept","volume":"6","author":"Reichel","year":"2009","journal-title":"Chem Biodivers"},{"key":"10.1124\/jpet.116.234146_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hbm.460010303","article-title":"Human brain atlas: For high-resolution functional and anatomical mapping","volume":"1","author":"Roland","year":"1994","journal-title":"Hum Brain Mapp"},{"key":"10.1124\/jpet.116.234146_bib37","first-page":"235","article-title":"Performance of a passive avoidance response is disrupted by compounds acting at 5HT(1A) receptors","volume":"1","author":"Sanger","year":"1989","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.116.234146_bib38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.nucmedbio.2012.10.011","article-title":"Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate","volume":"40","author":"Schou","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1124\/jpet.116.234146_bib39","doi-asserted-by":"crossref","first-page":"pyv036","DOI":"10.1093\/ijnp\/pyv036","article-title":"Large variation in brain exposure of reference CNS drugs: a PET study in nonhuman primates","volume":"18","author":"Schou","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.116.234146_bib40","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.euroneuro.2013.01.002","article-title":"5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects","volume":"23","author":"Stenkrona","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.116.234146_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1517\/17460441.1.6.595","article-title":"In vitro prediction of brain penetration\u2014a case for free thinking?","volume":"1","author":"Summerfield","year":"2006","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/jpet.116.234146_bib42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/dmd.108.024745","article-title":"Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport","volume":"37","author":"Syv\u00e4nen","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.116.234146_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00213-012-2901-z","article-title":"SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study","volume":"226","author":"Takano","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.234146_bib44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-011-2165-z","article-title":"Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369","volume":"213","author":"Varn\u00e4s","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.234146_bib45","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00259-009-1156-3","article-title":"Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT","volume":"36","author":"Varrone","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.234146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:47:50Z","timestamp":1739994470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524193949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0022356524193949"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.234146","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.234146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}